Loading...
Loading...
Heska Corporation
, a provider of advanced veterinary diagnostic
and other specialty veterinary products, announced today that its Board of
Directors has approved a $1.00 per share increase, from $8.50 to $9.50, in
the offer price for each share of its common stock held by stockholders who
owned, of record or beneficially, 99 or fewer shares as of the close of
business on August 21, 2012, and who continue to hold such shares through the
expiration of the offer. This increased offer price reflects premiums of 18%
and 5.3% over the last share sales price of the Company's common stock on the
record date and September 21, 2012, respectively. The Company's Board of
Directors has also approved an extension of the expiration date for this
odd-lot tender offer from 5:00 p.m. Eastern time on October 2, 2012 to 5:00
p.m. Eastern time October 15, 2012.
Participants in the odd-lot tender offer are to receive the Company's recently
announced dividend of $0.10 per share payable on October 10, 2012 regardless
of whether the underlying shares have already been tendered or are tendered
before or after the September 28, 2012 record date.
In addition, the Company filed today with the Securities and Exchange
Commission ("SEC") an amendment to the Company's Schedule TO on Schedule
13E-3. This amendment was filed (1) to reflect a change in SEC filing form
from Schedule TO to Schedule 13E-3 in response to a request of the SEC and (2)
to reflect the increase in price per share offered by the Company and
corresponding extension of the expiration date for the offer, as described
above. Notwithstanding this filing on Schedule 13E-3 rather than on Schedule
TO, the Company and its board of directors have not changed their previously
announced intentions for this offer and still currently intend for the Company
to remain a public company for the foreseeable future, with its shares of
common stock to remain listed on the Nasdaq Stock Market after the completion
of the offer, regardless of whether the completion of the offer results in the
Company having less than 300 stockholders of record. There can be no assurance
given, however, that the board of directors will not determine at a later date
to terminate the registration of the Company's common stock and its listing on
the Nasdaq Stock Market if doing so is deemed by the board of directors at
that time to be in the best interests of the Company and its stockholders.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in